These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Clinical Experience With High-Dosage Pramipexole in Patients With Treatment-Resistant Depressive Episodes in Unipolar and Bipolar Depression. Fawcett J; Rush AJ; Vukelich J; Diaz SH; Dunklee L; Romo P; Yarns BC; Escalona R Am J Psychiatry; 2016 Feb; 173(2):107-11. PubMed ID: 26844792 [No Abstract] [Full Text] [Related]
14. Attrition factors in clinical trials of comorbid bipolar and substance-related disorders. Nomamiukor N; Brown ES J Affect Disord; 2009 Jan; 112(1-3):284-8. PubMed ID: 18511129 [TBL] [Abstract][Full Text] [Related]
15. Pramipexole for bipolar II depression: a placebo-controlled proof of concept study. Zarate CA; Payne JL; Singh J; Quiroz JA; Luckenbaugh DA; Denicoff KD; Charney DS; Manji HK Biol Psychiatry; 2004 Jul; 56(1):54-60. PubMed ID: 15219473 [TBL] [Abstract][Full Text] [Related]
16. Use of the D2/D3 receptor agonist pramipexole in treatment of rapid-cycling bipolar disorder in an elderly patient. Mah L; Conn DK Am J Geriatr Psychiatry; 2010 Mar; 18(3):276. PubMed ID: 20224522 [No Abstract] [Full Text] [Related]
17. Adjunctive dopamine agonists in treatment-resistant bipolar II depression: an open case series. Perugi G; Toni C; Ruffolo G; Frare F; Akiskal H Pharmacopsychiatry; 2001 Jul; 34(4):137-41. PubMed ID: 11518474 [TBL] [Abstract][Full Text] [Related]
18. Assessing efficacy/effectiveness and safety/tolerability profiles of adjunctive pramipexole in bipolar depression: acute versus long-term data. Dell'Osso B; Ketter TA Int Clin Psychopharmacol; 2013 Nov; 28(6):297-304. PubMed ID: 24081199 [TBL] [Abstract][Full Text] [Related]
19. Fibromyalgia and pramipexole: promise and precaution. Holman AJ J Rheumatol; 2003 Dec; 30(12):2733. PubMed ID: 14719231 [No Abstract] [Full Text] [Related]